Women across the country are wondering whether to hope for a Yaz settlement in 2012. Some clients have been involved in the Yaz litigation since 2009 and are ready for some (hopefully good) news. Although the initial Yaz trials were originally scheduled for the end of 2011, and were later rescheduled for January and February, 2012, delays keep moving the possibility of a Yaz settlement back.
All of that may be about to ...
continue reading...FDA Advisory Panel Votes to Require Updated WarningsOn December 8, 2011, an FDA advisory panel held 9 hours of hearings about Yaz and Yasmin birth control and the risk of blood clots. Testimony included information about several large, independent studies that showed an increased risk. The panel also heard from the family of a young woman who used another birth control for months with no problems. She switched to Yaz, ...
continue reading...The Canadian Medical Journal published an article today by Dr. Gronich from the Department of Community Medicine and Epidemiology, looking at approximately 330,000 women taking various birth control pills. Overall, they found that drospirenone, an ingredient in Yaz, Yasmin, Ocella, and Beyaz, had a 65% increased risk of causing blood clots when compared more established birth control pills, ...
continue reading...December 8 Meeting Scheduled to Discuss 6 Studies Showing Increased Risk of Blood ClotsThe FDA will hold hearings next month to consider the risks of blood clots associated with Yaz, Yasmin, Ocella, and Beyaz. Although approximately six studies now show an increased risk, the FDA has not yet determined whether to officially update the warnings on these pills. The agency is widely expected to make a decision at or shortly ...
continue reading...Large study shows “significantly higher risk” compared with “low-estrogen” pillsThe FDA announced today that it has published a large retrospective study showing that women on birth control pills that contain drospirenone, an ingredient in Yaz, Yasmin, Ocella, and Beyaz, are approximately 75% more likely to have a blood clot than women on safer, established birth control pills.
Combined with the Danish study announced in the New York Times this ...
continue reading...Yet Another Study Shows Increased Risk of Blood Clots for Yaz, Yasmin,Ocella, and Beyaz The New York Times announced today that “A new study of 1.3 million Danish women over nine years adds to the evidence that some newer birth-control pills, including the best-seller Yaz, have a higher risk of causing potentially dangerous blood clots.” That makes approximately 5 studies in recent years suggesting a higher risk of blood clots ...
continue reading...
